SGRY · Surgery Partners, Inc.
$14.28
+1.13% last session
End-of-day data · close of 2026-09-11
Market cap
$2B
Enterprise value
$7B
Trailing P/E
—
Forward P/E
22.5
Dividend yield
—
Beta
1.92
Avg volume
2M
Employees
16K
Daily Change %
1.13%
5 Days Change
-0.98%
10 Days Change
1.66%
30 Days Change
-5.87%
60 Days Change
-13.90%
Month to Day Change
-3.29%
Year to Day Change
-8.61%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — SGRY
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-08-11
Latest call per bank · past 12 months
RBC Capital
Outperform$19.00
+34.6% vs priceUBS
Buy$21.00
+48.7% vs priceBarclays
Equal-Weight$14.00
-0.8% vs priceJP Morgan
Neutral$20.00
+41.6% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-11 | TD Cowen | Maintains | Buy | $17.00 → $19.00 |
| 2026-08-11 | RBC Capital | Maintains | Outperform | $20.00 → $19.00 |
| 2026-08-11 | Cantor Fitzgerald | Reiterates | Overweight | $18.00 |
| 2026-03-05 | TD Cowen | Maintains | Buy | $28.00 → $20.00 |
| 2026-03-05 | UBS | Maintains | Buy | $29.00 → $21.00 |
| 2026-03-05 | Mizuho | Maintains | Outperform | $19.00 → $17.00 |
| 2026-03-04 | RBC Capital | Maintains | Outperform | $31.00 → $20.00 |
| 2026-03-03 | Barclays | Maintains | Equal-Weight | $18.00 → $14.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 48 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 5.9% below the 50-day MA ($15.18).
- Price vs 200-day MA: Trading 3.0% below the 200-day MA ($14.72).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is positive (+0.07) — short-term momentum is improving.
- 52-week range: Price sits between the 52-week low ($11.49) and high ($22.94).
SGRY Price Chart
Loading chart for SGRY…
Fundamentals
About Surgery Partners, Inc.
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
More in Medical Care Facilities
HCA
HCA Healthcare, Inc.
$93B -9.3% YTD
THC
Tenet Healthcare Corporation
$21B 35.4% YTD
FMS
Fresenius Medical Care AG
$12B -2.5% YTD
EHC
Encompass Health Corporation
$12B 15.1% YTD
DVA
DaVita Inc.
$12B 61.1% YTD
UHS
Universal Health Services, Inc.
$10B -19.1% YTD
ENSG
The Ensign Group, Inc.
$10B -1.3% YTD
CHE
Chemed Corp
$7B 21.7% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.